Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP): A strategy from the DRSP Working Group

JAMA

Volumn 275, Issue 3, 1996, Pages 206-209

  Jernigan, Daniel B ^a   Cetron, Martin S ^a   Breiman, Robert F ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; HEALTH PROGRAM; HUMAN; LABORATORY DIAGNOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0030053607     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.275.3.206     Document Type: Review

References (34)

1. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;71:1831-1835.
2. Reichler MR, Allphin AA, Breiman RF, et al. The spread of multiply-resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis. 1992;166:1346-1353.
3. Stool SE, Field MJ. The impact of otitis media. Pediatr Infect Dis J. 1989;8:S11-S14.
4. Tilghman RC, Finland M. Clinical significance of bacteremia in pneumococcal pneumonia. Arch Intern Med. 1937;59:602-619.
5. Caputo GM, Appelbaum PC, Liu HH. Infections due to penicillin-resistant pneumococci: clinical, epidemiologic, and microbiologic features. Arch Intern, Med. 1993;153:1301-1307.
6. Jacobs MR, Koornhof HJ, Robins-Browne RM, et al. Emergence of multiply resistant pneumococci. N Engl J Med. 1978;299:735-740.
7. Applelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis. 1992;15:77-83.
8. Block SL, Harrison CJ, Hedrick JA, et al, Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk actors, susceptibility patterns, and antimicrobial management. Pediatr Infect Dis J. 1995;14:751-759.
9. Centers for Disease Control and Prevention. Drug-resistant Streptococcus pneumoniae - Kentucky and Tennessee, 1993. MMWR Morb Mortal Wkly Rep. 1994;43:23-25,31.
10. Centers for Disease Control and Prevention. Prevalence of penicillin-resistant Streptococcus pneumoniae - Connecticut, 1992-1993. MMWR Morb Mortal Wkly Rep. 1994;43:216-217,223.
11. Hofmann J, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med. 1995;333:481-486.
12. Sloas MM, Barrett FF, Chesney PJ, et al. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1992;11:662-666.
13. Chandy CJ. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin Infect Dis. 1994;18:188-193.
14. Bradley JS, Connor JD. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr Infect Dis J. 1991;10:871-873.
15. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med. 1995;333:474-480.
16. US Dept of Health and Human Services. Healthy People 2000: National Health Promotion and Disease Prevention Objectives. Washington, DC; US Dept of Health and Human Services; 1990. DHHS publication PHS 91-50213.
17. Centers for Disease Control and Prevention. Influenza and pneumococcal vaccination coverage levels among persons aged ≥65 years. MMWR Morb Mortal Wkly Rep. 1995;44:506-507, 513-515.
18. MeCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA 1995;273:214-219.
19. McGowan JE. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis. 1983;5:1033-1048.
20. Radetsky MS, Istre GR, Johansen TL, et al. Multiply resistant pneumococcus causing meningitis: its epidemiology within a day care center. Lancet. 1981;2:771-773.
21. Baquero F, Martinez-Beltran J, Loza E. A review of antibiotic resistance patterns of Streptococcus pneumoniae in Europe. J Antimicrob Chemother. 1991;28(suppl C):31-38.
22. Duchin JS, Breiman RF, Diamond A, et al. High prevalence of multidrug-resistant Streptococcus pneumoniae among children in a rural Kentucky community. Pediatr Infect Dis J. 1995;14:745-750.
23. Shlaes D, Levy S, Archer G. Antimicrobial resistance: new directions. ASM News. 1991;57:455-458.
24. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1994: 14-16.
25. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. 5th informational supplement. Villanova, Pa: National Committee for Clinical Laboratory Standards; 1994. NCCLS document M100-S5.
26. Jorgensen JH, Swenson JM, Tenover FC, Ferraro MJ, Hindler JA, Murray PR. Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae. J Clin Microbiol. 1994;32:2448-2459.
27. Jernigan DB, Cetron MS, Paul SM, Jessop A, Spitalny KC, Breiman RF. Laboratory-based surveillance for drug-resistant Streptococcus pneumoniae: assessment of laboratory methods and plan for implementation. In: Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology; 1995: 41. Abstract.
28. CarroU K, Cohen S, Saxon B, Hamilton L. Failure of Micro Media FOX Microdilution System to detect decreased susceptibility of Streptococcus pneumoniae to penicillin. J Clin Microbial. 1991; 29:2651-2652.
29. Shanholtzer CJ, Peterson LR. False susceptible penicillin G MIC's for Streptococcus pneumoniae with a commercial microdilution system. Am J Clin Pathol. 1986;85:626-629.
30. Centers for Disease Control and Prevention. National surveillance for infectious diseases, 1995. MMWR Morb Mortal Wkly Rep. 1995;44:737-739.
31. Fedson DS, Musher DM. Pneumoeoccal vaccine. In: Plotkin SA, Mortimer EA, eds. Vaccines. Philadelphia, Pa: WB Saunders Co; 1994:543-544.
32. Revenge of the killer microbes: losing the war against infectious disease. Time. September 12, 1994; 144:62-69.
33. Garrett L. The Coming Plague: Newly Emerging Diseases in a World Out of Balance. New York, NY: Farrar Straus & Giroux; 1994:411.
34. Institute of Medicine. Emerging Infections: Microbial Threats to Health in the United States. Washington, DC: National Academy Press; 1992: 92-94.